The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

If you’re exploring fertility treatments, you might have come across Lupride injections. Knowing about what Lupride is, how ...

The global injection pen market is expected to grow at a rate of 7% over the next five years. Key factors fueling this growth include the rising prevalence of chronic diseases, the increasing demand ...

At AHA 2025, data from the SCORE-HF study (NCT07141914) were presented, evaluating Novo Nordisk’s semaglutide 2.4mg and its ...

Sometime  within the last fortnight, several engagements with readers convinced yours truly that some degree of education was necessary about the dangers ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from five medicines that Pharmac will fund from 1 December 2025.

“Today’s decisions show the culture we are building at Pharmac. Pharmac listened to what patients want. They funded medicines to make patients’ lives easier, and reduce strain on the health system,” ...

Incyte (NASDAQ: INCY) and Enable Injections have formed a strategic partnership to co-develop and commercialize targeted cancer therapies using Enable’s enFuse® On-Body Delivery System, ...

A group of patients with advanced breast cancer will be the first to be able to receive a taxpayer-funded medicine in private ...

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to fund access to ...

If successful in the Phase III trial, VK2735 would enter direct competition with established dual agonists such as Eli ...